RECTUM CANCER
Clinical trials for RECTUM CANCER explained in plain language.
Never miss a new study
Get alerted when new RECTUM CANCER trials appear
Sign up with your email to follow new studies for RECTUM CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for Hard-to-Treat colorectal cancer
Disease control OngoingThis study tests a combination of two drugs, cabozantinib and nivolumab, in people with advanced colorectal cancer that has not responded to standard treatments. The goal is to see if the combination can stop or shrink the cancer for at least 16 weeks. About 48 adults with a spec…
Matched conditions: RECTUM CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
Boosting Cancer-Killing cells: a new combo therapy trial
Disease control TerminatedThis early-phase trial tests whether giving healthy donor NK cells along with two drugs (vactosertib and IL-2) is safe and helps the cells survive longer in people with advanced colorectal, stomach/esophageal, or blood cancers. About 12 participants will receive the combination t…
Matched conditions: RECTUM CANCER
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated May 11, 2026 20:48 UTC